Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif. About LEO Pharma LEO Pharma is a global company dedicated to advancing the standard of care through ...

The programmes are aimed at treating individuals with inflammatory conditions. Gilead will acquire LEO Pharma's preclinical oral STAT6 small molecule inhibitors and targeted protein degraders.

FOSTER CITY, Calif. & BALLERUP, Denmark, January 11, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) and LEO Pharma today announced a strategic partnership to accelerate the development and ...